Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S de Boer

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
Hepatology (Baltimore, Md.)|November 12, 2018
17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver DiseaseYanling Ma, Olga V Belyaeva, Philip M Brown, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 3, 2023
Importance of complete response for outcomes of pregnancy in patients with autoimmune hepatitisSusan E Fischer, Elsemieke S de Vries, Maarten E Tushuizen, et al.
Hepatology (Baltimore, Md.)|September 7, 2023
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registryCharlotte D Slooter, Floris F van den Brand, Ana Lleo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 5, 2013
Cytotoxic T lymphocyte antigen-4 +49A/G polymorphism does not affect susceptibility to autoimmune hepatitisNicole M F van Gerven, Ynto S de Boer, Antonie Zwiers, et al.
Alimentary Pharmacology & Therapeutics|August 16, 2018
Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the NetherlandsFloris F van den Brand, Carin M J van Nieuwkerk, Bart J Verwer, et al.
JHEP Reports : Innovation in Hepatology|July 8, 2024
Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapyAnna E C Stoelinga, Maaike Biewenga, Joost P H Drenth, et al.
United European Gastroenterology Journal|June 24, 2021
Development and validation of a prognostic score for long-term transplant-free survival in autoimmune hepatitis type 1Maaike Biewenga, Xavier P D M J Verhelst, Martine A M C Baven-Pronk, et al.
JHEP Reports : Innovation in Hepatology|May 13, 2026
Quantitative magnetic resonance cholangiopancreatography metrics improve prognostication in primary sclerosing cholangitisTim E Middelburg, Laura Cristoferi, Willemijn Ponsioen, et al.
Trials|January 17, 2024
Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trialAnna E C Stoelinga, Maarten E Tushuizen, Wilbert B van den Hout, et al.
Journal of Hepatology|October 6, 2023
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitisFrancesca Colapietro, Patrick Maisonneuve, Ellina Lytvyak, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Hepatology (Baltimore, Md.)|November 12, 2018
17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver DiseaseYanling Ma, Olga V Belyaeva, Philip M Brown, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 3, 2023
Importance of complete response for outcomes of pregnancy in patients with autoimmune hepatitisSusan E Fischer, Elsemieke S de Vries, Maarten E Tushuizen, et al.
Hepatology (Baltimore, Md.)|September 7, 2023
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registryCharlotte D Slooter, Floris F van den Brand, Ana Lleo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 5, 2013
Cytotoxic T lymphocyte antigen-4 +49A/G polymorphism does not affect susceptibility to autoimmune hepatitisNicole M F van Gerven, Ynto S de Boer, Antonie Zwiers, et al.
Alimentary Pharmacology & Therapeutics|August 16, 2018
Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the NetherlandsFloris F van den Brand, Carin M J van Nieuwkerk, Bart J Verwer, et al.
JHEP Reports : Innovation in Hepatology|July 8, 2024
Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapyAnna E C Stoelinga, Maaike Biewenga, Joost P H Drenth, et al.
United European Gastroenterology Journal|June 24, 2021
Development and validation of a prognostic score for long-term transplant-free survival in autoimmune hepatitis type 1Maaike Biewenga, Xavier P D M J Verhelst, Martine A M C Baven-Pronk, et al.
JHEP Reports : Innovation in Hepatology|May 13, 2026
Quantitative magnetic resonance cholangiopancreatography metrics improve prognostication in primary sclerosing cholangitisTim E Middelburg, Laura Cristoferi, Willemijn Ponsioen, et al.
Trials|January 17, 2024
Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trialAnna E C Stoelinga, Maarten E Tushuizen, Wilbert B van den Hout, et al.
Journal of Hepatology|October 6, 2023
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitisFrancesca Colapietro, Patrick Maisonneuve, Ellina Lytvyak, et al.
Pageof 14